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Fig. 1. 12-lead EInfective endocarditis (IE) complicated with ST-segment eleva-
tion myocardial infarction (STEMI) is a rare clinical condition usu-
ally due to coronary embolism, only rarely related to obstruction
or external compression by abscess formation [1]. Despite modern
diagnostic and therapeutic options, 1-year mortality has not
improved and is still around 30% [2]. Acute coronary syndrome
(ACS) has been reported in only 3% of all the patients with IE
and septic embolization, particularly from a prosthetic valve is a
very uncommon event, accounting only for < 1% of IE complica-
tions [3]. Herein, we report a case of fatal concomitant septic coro-
nary embolism and extrinsic coronary compression by abscess, in a
man with aortic prosthetic valve endocarditis (PVE).
A 77-year-old man has been admitted to our hospital for dysp-
noea and fever three months after a surgical aortic valve replace-
ment (SAVR) with bio-prosthesis for symptomatic severe aortic
stenosis (AS). Physical examination and Chest X-Ray were unre-ecommons.org
CG with ST-semarkable but laboratory tests showed increased inflammatory
markers (CRP 20 mg/l) and Staphylococcus aureus isolation in
blood cultures; thus, an empirical broad-spectrum antibiotic ther-
apy was initiated. Trans-thoracic echocardiography (TTE) showed
no vegetation and trans-oesophageal echocardiography (TOE)
was planned in a few days. Shortly thereafter, the patient pre-
sented sudden onset of left superior arm weakness: an urgent
Head CT scan was performed, showing only minimal chronic
ischaemic vascular signs. Rapidly, the patient developed progres-
sive hypoperfusions signs of left arm (cold, pale and disappearance
of arterial pulses) and typical chest pain. The 12-lead ECG showed
elevation up to 3 mm in V3-V5 (Fig. 1), and TTE showed newly
detected apical and septal akinesia with globally reduced systolic
function (left ventricular ejection fraction (LVEF) = 35%). The
patient underwent, indeed, to emergency coronary angiography
which showed contrast medium stasis in the left cusp just below
left main ostium and thrombotic occlusion of a diffusely diseased
left anterior descending artery (Fig. 2 Panel A). Despite multiple
aspirations, angioplasty with drug eluting stent implantation and
eptifibatide infusion, the control angiography displayed only a par-
tial reperfusion. TOE with 3D reconstruction revealed a 15 mm
perivalvular abscess with an 8 mm vegetation on the right aortic/licenses/by-nc-nd/4.0/).
gment elevation in V3-V5.
Fig. 2. Multimodality imaging; (Panel A): Coronary angiography: thrombotic occlusion of distal LAD (red arrow) and contrast medium stasis in the left cusp (white arrow);
(Panel B): TOE: short-axis view of aortic valve with evidence of vegetation (green crosses) in the right cusp and peri-valvular abscess (red arrow); (Panel C): Angio-CT scan:
prosthetic valve deterioration by IE (white arrow), re-occlusion of LAD (white arrows) and embolization of left axillary artery (red arrow); Ao: aorta; Axa: axillary artery; LAD:
left anterior descending; LCC: left coronary cusp; LM: left main; LP: left posterior; NCC: non-coronary cusp; RA: right anterior; Ra: right atrium; RCC: right coronary cusp;
RCx: ramus circumflexus artery; RV: right ventricle. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
A. Denegri, A. Venturelli and G. Boriani IJC Heart & Vasculature 32 (2021) 100711cusp, suggesting an IE (Fig. 2 Panel B). A CT scan confirmed, finally,
IE of the prosthetic aortic valve with left main involvement and
thrombotic occlusion of the left axillary artery, as result of septic
embolization (Fig. 2 Panel C). The rapidly worsening clinical condi-
tions did not allow a surgical evaluation and the patient died on
the same day from septic shock. This is a rare case of fatal con-
comitant septic coronary embolism and extrinsic coronary com-
pression by abscess.
Infective Endocarditis (IE) is the fourth most common life-
threatening infection; thus, a multidisciplinary management, as
suggested by current international Guidelines, is mandatory to
outcome improvement [4]. Risk factor for IE is a pre-existing valvu-
lar heart disease, such as mitral or aortic regurgitations, as result of
ageing population; a notably proportion of IE comes from the pres-
ence of a prosthetic valve, which accounts for 10–30% of total IE
cases and involves both biological and mechanical, particularly
for these latter within the first 3 months after surgery [5]. Diagno-
sis is based on integration of clinical, laboratory, imaging and
microbiological elements and current Guidelines recommend
modified Duke Criteria, that define IE diagnosis as Definite, Possi-
ble, or Rejected [6].
Clinical presentation of IE, particularly in PVE, is frequently
aspecific with fever, loss of appetite, a new heart murmur, left bun-
dle branch block, heart failure, or embolic events as most frequent
symptoms and signs. Echocardiography may be negative in PVE
and does not rule out the diagnosis, but can identify a new leak
involving the prosthetic valve (major criterion), and eventually
motivate additional imaging modalities (such as TOE and CT scan)
[7].
Myocardial infarction from septic embolization is a rare but
serious complication of IE, conferring an increase mortality risk,
if present [8]. Clinical presentation in this population may influ-
ence physician to apply traditional management strategies for
atherosclerotic disease with poor results [9].2
There are no current practice guidelines for management of
STEMI in IE setting, but thrombolytics (Tissue Plasminogen Activa-
tor) appear to be harmful, leading to significant bleeding and
embolic risks. Surgical intervention, with debridement of necrotic
and infected tissue, drainage of abscess and reconstruction of car-
diac morphology with repair or replacement of diseased valve is
often the only chance for these patients, burdened, however, by
a high risk of mortality [10].
Our case report describes a particularly rare event: the combi-
nation of septic coronary embolism and extrinsic coronary com-
pression by abscess, in a patient with prosthetic valve endocarditis.Declaration of Competing Interest
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